Cuba in third stage trial process for advanced prostate cancer vaccine

Published On 2015-08-22 04:38 GMT   |   Update On 2015-08-22 04:38 GMT
Advertisement
A Cuban vaccine, currently under trial stage process will now enter its third phase of the trail process, to be tested on 300 patients, confirmed the specialists to PTI. The vaccine's first phase of trial took place in 2007 and the second phase concluded in early 2015.

In this stage, researchers at the Centre for Genetic Engineering and Biotechnology (CIGB), where the vaccine Heberprovac was developed, will compare its performance with that of Zoladex, a well known therapy used internationally to treat various types of neoplasms, reported Xinhua.
Advertisement

Researchers from CIBG consider Heberprovac to be already superior to Zoladex in its administration format, needing only seven shots; while the Zoladex, which is also used to treat breast cancer, must be administered every three months via a sub-cutaneous implant.

The specialists say that while Heberprovac has not yet been proven to be a cure for prostate cancer, it has led to "a greater survival rate and better quality of life" in the majority of patients treated with it.
Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News